Goldman's Q3 Beat Relies on Strong Equities and Deal Revenue

CVS Health raised its 2026 outlook after a stronger second quarter, but the upgraded numbers do not eliminate the central concern surrounding the stock: whether medical costs and insurance margins can improve sustainably.

The company now expects at least $414 billion in full-year revenue, up from a prior floor of $405 billion. Adjusted earnings are projected at $7.90 to $8.10 a share, compared with the previous $7.30 to $7.50 range. Management also lifted expected cash flow from operations to at least $11.5 billion from at least $9.5 billion.

Second-quarter revenue reached $106.1 billion, an increase of 7.3% from a year earlier, and adjusted EPS was $2.58. CVS said its medical benefit ratio improved, an important signal because that measure shows how much premium revenue is being consumed by members’ medical care. Even a modest change can have a large effect on insurance earnings.

The raised guidance is concrete evidence of a better year than management expected several months ago. It also shifts the debate. Investors no longer need only proof that 2026 results can stabilize. They need to judge how much of the improvement can carry into 2027, when pricing, utilization and Medicare Advantage economics will again shape performance.

Cash generation gives CVS room to reduce leverage, invest in its health-services platform and maintain the dividend. Yet the company’s integrated model also creates several moving parts. Pharmacy reimbursement, insurance utilization, retail-store productivity and the performance of acquired care assets can offset one another from quarter to quarter.

The stock chart may respond to near-term momentum, but the more useful operating markers are the medical benefit ratio, realized cost savings and the conversion of adjusted earnings into cash. The revised forecast sets a higher baseline for 2026. It does not guarantee that the margin recovery will be smooth, and management will now be judged against expectations it has raised twice: first by improving the year, and then by showing that the improvement is durable.

Hewlett Packard Enterprise's third-quarter numbers looked unusually strong: revenue rose 32.7% to $12.2 billion, server revenue increased 35.3% and networking revenue climbed 74.9%. The valuation debate begins with a basic adjustment. Much of the networking jump reflects the addition of Juniper Networks, so the headline growth rate is not a clean measure of organic momentum.

The acquisition still changes HPE's earnings mix in a useful way. Networking generated a 22% operating margin in the quarter, well above the economics associated with many server systems. HPE also expects at least $600 million of annualized Juniper cost savings by the end of fiscal 2028, and it has since raised that ambition to $800 million.

The server business supplies the other side of the story. AI systems are driving orders, but servers are competitive, capital-intensive products. Customers can switch vendors, component costs move quickly and large deployments can produce substantial revenue without equally strong margins. That is why a low forward earnings multiple may reflect skepticism about durability rather than a simple market mistake.

HPE's official third-quarter release reported networking revenue of $2.9 billion, up 74.9%, with a 22.0% operating margin. Orders grew faster than revenue in parts of the portfolio, while memory and supply constraints affected the timing of shipments. Those conditions can push sales between quarters.

Juniper gives HPE a better chance to build recurring relationships through networking software, security and operations tools. GreenLake can add consumption-based revenue, but investors still need proof that retention and usage are strengthening rather than merely financing hardware purchases.

The clean test is mix and cash generation. HPE must show normalized networking growth after acquisition effects fade, deliver the promised savings and convert AI demand into free cash flow. If it does, the earnings multiple can rise. If server demand normalizes before networking becomes a durable profit engine, today's apparent discount may be justified.

Vertiv’s selloff has made the stock cheaper, but not cheap enough to excuse an ordinary quarter. The shares closed at $206.08 on October 19 after a 15% weekly decline, while the next-twelve-month earnings multiple fell from about 49 times in June to roughly 26 times.

The valuation reset occurred even as next-twelve-month earnings estimates increased from about $6.80 to $7.90 per share, according to TIKR. That creates a clear test for the October 28 earnings report: investors need evidence that demand is converting into both sales and better factory economics.

Vertiv guided third-quarter sales to $3.65 billion to $3.85 billion and adjusted operating profit to $898 million to $938 million. The implied adjusted operating margin is about 24% to 25%. Consensus operating profit near $924 million already sits above the midpoint, so merely landing in the range may not be enough.

The operational detail matters. Chief Financial Officer Craig Chamberlin has linked the company’s goal of an adjusted operating margin above 27% by 2030 to volume leverage, labor productivity, purchasing and plant overhead. Vertiv then appointed Michael Resha to lead manufacturing, logistics and operational excellence. Investors now have a named executive and measurable margin path to assess.

The company’s second-quarter results showed the risk of a high-expectation stock. Sales of $3.27 billion missed consensus in the source by about 3.2%, and the shares dropped more than 17% that day. Vertiv later raised full-year guidance, confirming that AI infrastructure demand remained strong, but the market still penalized imperfect execution.

The October report should therefore be judged on orders, backlog conversion, sales, adjusted margin and commentary on plant productivity. Profit above the top of guidance with steady demand would support the idea that the multiple compression has gone too far. A result below the midpoint, or weaker order visibility, would make the lower multiple look less like an opportunity and more like a warning.

Bloom Energy shares slipped more than 2% in overnight trading before its third-quarter report, as investors focused on a valuation that assumes rapid growth and clean execution.

The source cited a trailing price-to-earnings ratio of roughly 255 times and a forward multiple of 63.5 times. Those figures are not directly comparable with every industrial peer because earnings quality, growth and business mix differ, but they show how much optimism is embedded in the stock. The same report placed Cummins near 15.9 times forward earnings and GE Vernova near 43.2 times.

Growth can support a premium, but it must arrive in the financial statements. Analysts cited by Stocktwits expected third-quarter revenue of about $1.06 billion, more than double the prior-year period, and adjusted earnings per share of $0.70 versus $0.15. Bloom had also raised full-year revenue guidance to $3.9 billion to $4.2 billion.

Backlog is not cash

Bloom’s reported backlog near $20 billion and its strategic agreement with Oracle create substantial potential demand. Oracle and Bloom have discussed deployments of up to 2.8 gigawatts of fuel-cell capacity for AI and cloud data centers, while Project Jupiter alone could use up to 2.45 gigawatts.

Investors should distinguish announced capacity, contracted backlog, delivered systems and recognized revenue. Each stage carries different timing, margin and working-capital risks. A manufacturer can post fast sales growth while consuming cash if inventory, receivables and capacity spending rise faster.

The third-quarter report therefore needs to answer more than whether revenue beat expectations. Gross margin, operating cash flow, backlog quality and the schedule for large Oracle-related deployments will determine whether the valuation is anchored in earnings or still rests mainly on future capacity.

A premium multiple is not automatically excessive for a company growing this quickly. It does make the stock less forgiving. If project schedules slip or margins disappoint, even a strong headline growth rate may not be enough.

Coca-Cola's second quarter was strong enough to support optimism and detailed enough to show where that optimism could fail.

The company reported 5% growth in global unit case volume, 7% net revenue growth and 6% organic revenue growth. Operating margin rose to 34.9% from 34.1%, while comparable margin increased to 35.6% from 34.7%. Those results show that investment in demand did not prevent companywide margin expansion.

Management also acknowledged continued pressure on lower-income consumers across markets. Coca-Cola generated three percentage points of price and mix growth, but unfavorable mix reduced the result by one point, partly because of the timing of investment in Asia-Pacific. The region grew volume across its operating units while comparable operating income declined.

That tension matters because the shares had risen sharply and traded at a rich sales multiple in the source analysis. When expectations are high, an extra point of promotional or affordability spending can matter more to the share price than it does to near-term revenue.

The investor question is not whether Coca-Cola can sell beverages during a difficult consumer period. The reported volume growth suggests it can. The question is how much pricing and marketing support is required, and whether lower-income pressure spreads from selected markets into a broader margin problem.

Price and mix should be read alongside volume. Higher price with falling volume can weaken a brand over time, while volume bought through heavy spending can dilute profit. Coca-Cola's second quarter balanced the two well at the consolidated level, but Asia-Pacific shows that the balance can differ by region.

The bullish case remains supported by growth and margin expansion. The risk is that a highly valued stock leaves little room for affordability investment to become a persistent drag.